MorphoSys AG American Depositary Shares
MOR was delisted on the 2nd of August, 2024.
23 hedge funds and large institutions have $17.3M invested in MorphoSys AG American Depositary Shares in 2022 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 3 increasing their positions, 13 reducing their positions, and 13 closing their positions.
34% less funds holding
Funds holding: 35 → 23 (-12)
39% less capital invested
Capital invested by funds: $28.5M → $17.3M (-$11.2M)
77% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 13
85% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 13
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
+$3.43M |
| 2 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
+$1.08M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
+$459K |
| 4 |
CFM
Capricorn Fund Managers
London,
United Kingdom
|
+$193K |
| 5 |
JP Morgan Chase
New York
|
+$4.67K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$479K |
| 2 |
Renaissance Technologies
New York
|
-$469K |
| 3 |
Two Sigma Investments
New York
|
-$468K |
| 4 |
BlackRock
New York
|
-$431K |
| 5 |
Jane Street
New York
|
-$402K |
MOR Hedge Fund Activity: Q1 2022 in Review
23 of the 6,360 institutional investors tracked by Wall St. Rank reported a position in MorphoSys AG American Depositary Shares (MOR) for Q1 2022, worth a combined $17.3M — down 39% from $28.5M a quarter earlier.
Sellers outnumbered buyers: 13 funds closed out of MOR and 2 opened new positions — a net loss of 11 holders — while 13 trimmed existing stakes and 3 added.
The largest buyer was Millennium Management, adding an estimated $3.43M. The largest seller was Citadel Advisors, exiting entirely with an estimated $479K sold.
- 23 institutional investors held MorphoSys AG American Depositary Shares (MOR) as of Q1 2022, down from 35 in Q4 2021.
- Funds reported $17.3M of MorphoSys AG American Depositary Shares stock for Q1 2022, down 39% quarter-over-quarter.
- 2 funds opened new MorphoSys AG American Depositary Shares positions in Q1 2022 and 13 closed out, a net change of -11 holders.
- The largest MorphoSys AG American Depositary Shares buyer in Q1 2022 was Millennium Management, an estimated $3.43M added.
- The largest MorphoSys AG American Depositary Shares seller in Q1 2022 was Citadel Advisors, an estimated $479K sold.
Based on aggregated 13F filings for Q1 2022.